Skip to content

Drug interactions

Pacritinib + Verapamil

Severity: Major

Pacritinib and Verapamil: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib is metabolized mainly by CYP3A4, and verapamil is a moderate CYP3A4 inhibitor. Concurrent use can raise pacritinib exposure and increase the risk of adverse effects such as QT prolongation, bleeding and diarrhea.

What this interaction means in plain words

Pacritinib and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Pacritinib belongs to Oncology; Verapamil belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Verapamil inhibits CYP3A4-mediated metabolism of pacritinib, raising its plasma concentrations.

What to do

Avoid the combination where possible, and consider a non-interacting antihypertensive or antiarrhythmic. If it cannot be avoided, monitor ECG and QTc and watch for pacritinib toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pacritinib and Verapamil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pacritinib with Verapamil?

MediHelp rates the interaction as major. Pacritinib and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pacritinib is metabolized mainly by CYP3A4, and verapamil is a moderate CYP3A4 inhibitor. Concurrent use can raise pacritinib exposure and increase the risk of adverse effects such as QT prolongation, bleeding and diarrhea.

How serious is the interaction between Pacritinib and Verapamil?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, and consider a non-interacting antihypertensive or antiarrhythmic. If it cannot be avoided, monitor ECG and QTc and watch for pacritinib toxicity.

What other medicines interact with Verapamil?

MediHelp also lists interactions of Verapamil with, for example, Dofetilide, Flibanserin, Lomitapide. The full list is on the Verapamil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in